Retatrutide (LY3437943) is an investigational peptide studied for its activity at multiple metabolic hormone receptors, including GLP-1, GIP, and glucagon receptors. It has been evaluated in clinical research related to metabolic and endocrine signaling pathways and is being explored for its potential role in weight and energy regulation mechanisms.